CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on developing cyclodextrin-based nanocarriers for the effective delivery of antibiotics to combat antibiotic-resistant bacteria. It aims to enhance drug stability, bioavailability, and patient compliance while reducing side effects and treatment duration, particularly for tuberculosis and other hosp…
The worldwide spread of antibiotic-resistant microorganisms can be viewed as an ecological consequence of the systematic use of antimicrobial agents.
Resistant bacteria prevail in healthcare environments where antibiotic selective pressure is intensive.
Novel therapeutic approaches are urgently required to deliver the well-documented existing drugs in an optimized fashion to: i) protect them toward degradation; ii) increase their bioavailability; iii) reduce toxic side effects; iv) increase pati…
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Greece, Agia Paraskevi
Type: Research institute
Activity type: Research Organisations
SME: No
Spain, Ciudad Real
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Almeria
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Catania
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
